These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 19260677)

  • 1. Structure-activity relationships of orotidine-5'-monophosphate decarboxylase inhibitors as anticancer agents.
    Bello AM; Konforte D; Poduch E; Furlonger C; Wei L; Liu Y; Lewis M; Pai EF; Paige CJ; Kotra LP
    J Med Chem; 2009 Mar; 52(6):1648-58. PubMed ID: 19260677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships of C6-uridine derivatives targeting plasmodia orotidine monophosphate decarboxylase.
    Bello AM; Poduch E; Liu Y; Wei L; Crandall I; Wang X; Dyanand C; Kain KC; Pai EF; Kotra LP
    J Med Chem; 2008 Feb; 51(3):439-48. PubMed ID: 18189347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of orotidine-5'-monophosphate decarboxylase--discoveries and lessons.
    Kotra LP; Pai EF
    Nucleic Acids Symp Ser (Oxf); 2008; (52):85-6. PubMed ID: 18776265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A potent, covalent inhibitor of orotidine 5'-monophosphate decarboxylase with antimalarial activity.
    Bello AM; Poduch E; Fujihashi M; Amani M; Li Y; Crandall I; Hui R; Lee PI; Kain KC; Pai EF; Kotra LP
    J Med Chem; 2007 Mar; 50(5):915-21. PubMed ID: 17290979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of inhibitors of ODCase.
    Mundra S; Kotra LP
    Future Med Chem; 2014 Feb; 6(2):165-77. PubMed ID: 24467242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel cytidine-based orotidine-5'-monophosphate decarboxylase inhibitors with an unusual twist.
    Purohit MK; Poduch E; Wei LW; Crandall IE; To T; Kain KC; Pai EF; Kotra LP
    J Med Chem; 2012 Nov; 55(22):9988-97. PubMed ID: 22991951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of inhibitors of orotidine monophosphate decarboxylase using bioisosteric replacement and determination of inhibition kinetics.
    Poduch E; Bello AM; Tang S; Fujihashi M; Pai EF; Kotra LP
    J Med Chem; 2006 Aug; 49(16):4937-45. PubMed ID: 16884305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel interactions of fluorinated nucleotide derivatives targeting orotidine 5'-monophosphate decarboxylase.
    Lewis M; Meza-Avina ME; Wei L; Crandall IE; Bello AM; Poduch E; Liu Y; Paige CJ; Kain KC; Pai EF; Kotra LP
    J Med Chem; 2011 Apr; 54(8):2891-901. PubMed ID: 21417464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The in silico screening and X-ray structure analysis of the inhibitor complex of Plasmodium falciparum orotidine 5'-monophosphate decarboxylase.
    Takashima Y; Mizohata E; Krungkrai SR; Fukunishi Y; Kinoshita T; Sakata T; Matsumura H; Krungkrai J; Horii T; Inoue T
    J Biochem; 2012 Aug; 152(2):133-8. PubMed ID: 22740703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of carbocyclic orotidine analogs as potential orotidine decarboxylase inhibitors.
    Song GY; Naguib FN; el Kouni MH; Chu CK
    Nucleosides Nucleotides Nucleic Acids; 2001 Dec; 20(12):1915-25. PubMed ID: 11794797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of orotidine 5'-monophosphate decarboxylase and its therapeutic potential.
    Meza-Avina ME; Wei L; Buhendwa MG; Poduch E; Bello AM; Pai EF; Kotra LP
    Mini Rev Med Chem; 2008 Mar; 8(3):239-47. PubMed ID: 18336344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrate binding induces domain movements in orotidine 5'-monophosphate decarboxylase.
    Harris P; Poulsen JC; Jensen KF; Larsen S
    J Mol Biol; 2002 May; 318(4):1019-29. PubMed ID: 12054799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theoretical studies of the effect of thio substitution on orotidine monophosphate decarboxylase substrates.
    Phillips LM; Lee JK
    J Org Chem; 2005 Feb; 70(4):1211-21. PubMed ID: 15704953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural determinants for the inhibitory ligands of orotidine-5'-monophosphate decarboxylase.
    Meza-Avina ME; Wei L; Liu Y; Poduch E; Bello AM; Mishra RK; Pai EF; Kotra LP
    Bioorg Med Chem; 2010 Jun; 18(11):4032-41. PubMed ID: 20452222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and anticancer activity of a novel class of flavonoids: 2,4-diarylchromane[4,3-d]-delta(1,9b)-1,2,3-thiadiazolines.
    Ying H; Hu Y; He Q; Li R; Yang B
    Eur J Med Chem; 2007 Feb; 42(2):226-34. PubMed ID: 17137679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orotidine Monophosphate Decarboxylase--A Fascinating Workhorse Enzyme with Therapeutic Potential.
    Fujihashi M; Mnpotra JS; Mishra RK; Pai EF; Kotra LP
    J Genet Genomics; 2015 May; 42(5):221-34. PubMed ID: 26059770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure activity relationship studies of imidazo[1,2-a]pyrazine derivatives against cancer cell lines.
    Myadaraboina S; Alla M; Saddanapu V; Bommena VR; Addlagatta A
    Eur J Med Chem; 2010 Nov; 45(11):5208-16. PubMed ID: 20832916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lys314 is a nucleophile in non-classical reactions of orotidine-5'-monophosphate decarboxylase.
    Heinrich D; Diederichsen U; Rudolph MG
    Chemistry; 2009 Jul; 15(27):6619-25. PubMed ID: 19472232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and anticancer activities of amphiphilic 5-fluoro-2'-deoxyuridylic acid prodrugs.
    Ludwig PS; Schwendener RA; Schott H
    Eur J Med Chem; 2005 May; 40(5):494-504. PubMed ID: 15893023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of 2-phenylthiazole-4-carboxamide derivatives as anticancer agents.
    Aliabadi A; Shamsa F; Ostad SN; Emami S; Shafiee A; Davoodi J; Foroumadi A
    Eur J Med Chem; 2010 Nov; 45(11):5384-9. PubMed ID: 20846760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.